Clinical Trial: Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840729) titled 'Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants' on Sept. 20.

Brief Summary: Use these resources to provide understandable information about this study to patients, families, and health care providers:

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Valid MeSH Conditiongs

Intervention: DRUG: JMT206 injection

JMT206 injection administered subcutaneously (SC) once a week

COMBINATION_PRODUCT: Semaglutide injection

Semaglutide administered subcutaneously once a week, starts from lower dose and is gradually increased.

DRUG: Placebo injection

Placebo administered...